Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. (2021)

First Author: Alexander JL
Attributed to:  King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2021-002742

PubMed Identifier: 34233964

Publication URI: http://europepmc.org/abstract/MED/34233964

Type: Journal Article/Review

Volume: 9

Parent Publication: Journal for immunotherapy of cancer

Issue: 7

ISSN: 2051-1426